Technology Week Liechtenstein: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Week Liechtenstein.

Press releases published on October 19, 2026

Oct. 19, 2026

aTyr Pharma Announces Research Collaboration with Montefiore Einstein

Indeterminate GlobeNewswire

Oct. 19, 2026

Parabilis Medicines to Present Updated Clinical Data for Zolucatetide in Patients with Desmoid Tumors at ESMO Congress 2026

Indeterminate GlobeNewswire

Oct. 19, 2026

Ethyreal Bio Achieves Proof of Mechanism in First-in-Human Study of ETHY-001 and Initiates First Patient Cohorts to Advance Development in Thyroid Eye Disease (TED) and Graves’ Disease (GD)

Indeterminate GlobeNewswire

Oct. 19, 2026

Tonix Pharmaceuticals to Present an Analysis of Phase 3 Data on TONMYA® at the IASP 2026 World Congress on Pain

Indeterminate GlobeNewswire

Oct. 19, 2026

Pax8 Unveils The Managed Intelligence Guide: Navigating the Pax8 Ecosystem

Indeterminate GlobeNewswire

Oct. 19, 2026

Iovance Highlights TIL Cell Therapy Platform Across Solid Tumors at the European Society for Medical Oncology (ESMO) Congress 2026

Indeterminate GlobeNewswire

Oct. 19, 2026

Sylogist Announces CFO Transition, Appoints David Miller as Chief Operating Officer

Indeterminate GlobeNewswire

Oct. 19, 2026

Haleon Launches ‘Haleon Health House,’ a One-Day Interactive Wellness Pop-Up in Toronto

Indeterminate GlobeNewswire

Oct. 19, 2026

Agility Robotics Announces Audit Committee Chair for Planned Public-Company Board

Indeterminate GlobeNewswire

Oct. 19, 2026

EyePoint Announces Topline Results from LUCIA, the Second Pivotal Phase 3 Clinical Trial of DURAVYU™ in Wet AMD

Indeterminate GlobeNewswire

Oct. 19, 2026

Lexeo Therapeutics to Host Educational Event Focused on Clinical Endpoints and Outcome Measures in PKP2-ACM

Indeterminate GlobeNewswire

Oct. 19, 2026

Disc Medicine Announces Success on All Primary and Secondary Endpoints in the Pivotal Phase 3 APOLLO Trial of Bitopertin in Adults and Adolescents with Erythropoietic Protoporphyria (EPP)

Indeterminate GlobeNewswire

Oct. 19, 2026

Xanadu Secures Up to USD $10 Million in Additional DARPA Support to Accelerate Quantum R&D Roadmap

Indeterminate GlobeNewswire

Oct. 19, 2026

Bioxytran Completes Production of Two Dietary Supplements: V-LO® for Immune Health and A-SUQAR® for Healthy Blood Sugar

Indeterminate GlobeNewswire

Oct. 19, 2026

Owlting Group (NASDAQ: OWLS) Issues CEO Letter to Shareholders Marking One Year on Nasdaq

Indeterminate GlobeNewswire

Oct. 19, 2026

RETEVIS Marks 16 Years, Advancing Reliable Industrial Communication Solutions

Indeterminate GlobeNewswire

Oct. 19, 2026

ANI Pharmaceuticals Announces the Launch of Duloxetine Delayed-Release Capsules

Indeterminate GlobeNewswire

Oct. 19, 2026

BioNTech präsentiert auf dem ESMO-Kongress 2026 Fortschritte ihrer spätklinischen Onkologie-Pipeline und Daten zu innovativen Kombinationsansätzen mit Pumitamig

Indeterminate GlobeNewswire

Oct. 19, 2026

BioNTech to Showcase Oncology Late-Stage Pipeline Progress and Pumitamig Novel-Novel Combination Data at ESMO 2026

Indeterminate GlobeNewswire

Oct. 19, 2026

Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site

Indeterminate GlobeNewswire